IRIS Accounts Production v24.1.0.578 11403621 Board of Directors 1.8.22 31.7.23 31.7.23 0 false true false false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh114036212022-07-31114036212023-07-31114036212022-08-012023-07-31114036212021-07-31114036212021-08-012022-07-31114036212022-07-3111403621ns15:EnglandWales2022-08-012023-07-3111403621ns14:PoundSterling2022-08-012023-07-3111403621ns10:Director12022-08-012023-07-3111403621ns10:PrivateLimitedCompanyLtd2022-08-012023-07-3111403621ns10:SmallEntities2022-08-012023-07-3111403621ns10:AuditExempt-NoAccountantsReport2022-08-012023-07-3111403621ns10:SmallCompaniesRegimeForDirectorsReport2022-08-012023-07-3111403621ns10:SmallCompaniesRegimeForAccounts2022-08-012023-07-3111403621ns10:FullAccounts2022-08-012023-07-311140362112022-08-012023-07-3111403621ns10:OrdinaryShareClass12022-08-012023-07-3111403621ns10:Director22022-08-012023-07-3111403621ns10:RegisteredOffice2022-08-012023-07-3111403621ns5:CurrentFinancialInstruments2023-07-3111403621ns5:CurrentFinancialInstruments2022-07-3111403621ns5:ShareCapital2023-07-3111403621ns5:ShareCapital2022-07-3111403621ns5:SharePremium2023-07-3111403621ns5:SharePremium2022-07-3111403621ns5:RetainedEarningsAccumulatedLosses2023-07-3111403621ns5:RetainedEarningsAccumulatedLosses2022-07-311140362112022-08-012023-07-3111403621ns5:DevelopmentCostsCapitalisedDevelopmentExpenditure2022-08-012023-07-3111403621ns5:OwnedOrFreeholdAssetsns5:LandBuildings2022-08-012023-07-3111403621ns5:FurnitureFittings2022-08-012023-07-3111403621ns5:ComputerEquipment2022-08-012023-07-3111403621ns5:IntangibleAssetsOtherThanGoodwill2022-07-3111403621ns5:IntangibleAssetsOtherThanGoodwill2022-08-012023-07-3111403621ns5:IntangibleAssetsOtherThanGoodwill2023-07-3111403621ns5:IntangibleAssetsOtherThanGoodwill2022-07-3111403621ns5:LandBuildings2022-07-3111403621ns5:PlantMachinery2022-07-3111403621ns5:LandBuildings2022-08-012023-07-3111403621ns5:PlantMachinery2022-08-012023-07-3111403621ns5:LandBuildings2023-07-3111403621ns5:PlantMachinery2023-07-3111403621ns5:LandBuildings2022-07-3111403621ns5:PlantMachinery2022-07-3111403621ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-07-3111403621ns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-07-3111403621ns10:OrdinaryShareClass12023-07-31
REGISTERED NUMBER: 11403621 (England and Wales)













UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 JULY 2023

FOR

EVECLO HOLDINGS LIMITED

EVECLO HOLDINGS LIMITED (REGISTERED NUMBER: 11403621)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2023




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


EVECLO HOLDINGS LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 JULY 2023







DIRECTORS: A Reynolds
S D Embley





REGISTERED OFFICE: 30-34 North Street
Hailsham
East Sussex
BN27 1DW





REGISTERED NUMBER: 11403621 (England and Wales)





ACCOUNTANTS: Watson Associates (Professional Services) Ltd
30 - 34 North Street
Hailsham
East Sussex
BN27 1DW

EVECLO HOLDINGS LIMITED (REGISTERED NUMBER: 11403621)

BALANCE SHEET
31 JULY 2023

2023 2022
Notes £    £   
FIXED ASSETS
Intangible assets 4 - 648,239
Tangible assets 5 - 16,150
- 664,389

CURRENT ASSETS
Debtors 6 857,025 191,857
Cash at bank 874 66,545
857,899 258,402
CREDITORS
Amounts falling due within one year 7 (13,411 ) (78,303 )
NET CURRENT ASSETS 844,488 180,099
TOTAL ASSETS LESS CURRENT
LIABILITIES

844,488

844,488

CAPITAL AND RESERVES
Called up share capital 8 614,286 614,286
Share premium 315,714 315,714
Retained earnings (85,512 ) (85,512 )
SHAREHOLDERS' FUNDS 844,488 844,488

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 July 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 July 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 30 July 2024 and were signed on its behalf by:



A Reynolds - Director


EVECLO HOLDINGS LIMITED (REGISTERED NUMBER: 11403621)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2023

1. STATUTORY INFORMATION

Eveclo Holdings Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Critical accounting judgements and key sources of estimation uncertainty
In the application of the company's accounting policies, management is required to make judgements, estimates and assumptions about the carrying value of assets and liabilities that are not readily apparent from their sources. The estimates are underlying assumptions and are based on historical experience and other factors that are considered relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods.

The key sources of estimation uncertainty that have a significant effect on the amounts recognised in the financial statements are described below:

Capitalised development expenditure has been estimated based on 80% of specific subcontracted labour costs and apportioned salary costs, which is viewed as a fair reflection of costs attributable to developing products where there is expected to be future cash inflows to the company.

Turnover
Turnover is measured at the fair value of the consideration received or receivable and represents amounts receivable services rendered, stated net of discounts and of Value Added Tax. When the consideration receivable in cash or cash equivalents is deferred, and the arrangement constitutes in effect a financing transaction, the fair value of the consideration is measured as the present value of all future receipts determined using an imputed rate of interest, normally the rate that discounts the nominal amount of consideration to the cash sales price.

The company recognises revenue when the amount of revenue can be measured reliably, when it
is probable that future economic benefits will flow to the entity.

EVECLO HOLDINGS LIMITED (REGISTERED NUMBER: 11403621)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 JULY 2023

2. ACCOUNTING POLICIES - continued

Development expenditure
Development of products is capitalised where there is expected to be a benefit to future periods and the following conditions are met:

(i) It is technically feasible to complete the research and development so that the product will be available for use or sale

(ii) It is intended to use or sell the product being developed.

(iii) The Company is able to use or sell the product.

(iv) It can be demonstrated that the product will generate probable future economic benefits.

(v) Adequate technical, financial and other resources exist so that the product development can be competed and subsequently used or sold.

(vi) Expenditure attributable to the research and development work can be reliably measured.

Capitalised development expenditure is stated at cost less accumulated amortisation and impairment losses and amortised over it's economical useful life.

Amortisation begins when the intangible asset is available for use and is written off over it's estimated useful life of 5 years.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Freehold property - not provided
Fixtures and fittings - 20% on cost
Computer equipment - 33% on cost

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

EVECLO HOLDINGS LIMITED (REGISTERED NUMBER: 11403621)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 JULY 2023

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2022 - 13 ).

4. INTANGIBLE FIXED ASSETS
Other
intangible
assets
£   
COST
At 1 August 2022 890,246
Disposals (890,246 )
At 31 July 2023 -
AMORTISATION
At 1 August 2022 242,007
Eliminated on disposal (242,007 )
At 31 July 2023 -
NET BOOK VALUE
At 31 July 2023 -
At 31 July 2022 648,239

5. TANGIBLE FIXED ASSETS
Plant and
Land and machinery
buildings etc Totals
£    £    £   
COST
At 1 August 2022 8,320 31,950 40,270
Disposals (8,320 ) (31,950 ) (40,270 )
At 31 July 2023 - - -
DEPRECIATION
At 1 August 2022 - 24,120 24,120
Eliminated on disposal - (24,120 ) (24,120 )
At 31 July 2023 - - -
NET BOOK VALUE
At 31 July 2023 - - -
At 31 July 2022 8,320 7,830 16,150

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Trade debtors - 91,182
Amounts owed by group undertakings 857,025 -
Other debtors - 100,675
857,025 191,857

EVECLO HOLDINGS LIMITED (REGISTERED NUMBER: 11403621)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 JULY 2023

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Amounts owed to group undertakings - 1,770
Taxation and social security 12,106 47,124
Other creditors 1,305 29,409
13,411 78,303

8. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2023 2022
value: £    £   
614,286 Ordinary £1 614,286 614,286

9. RELATED PARTY DISCLOSURES

Included in other creditors is £1,306 (2022 - £9.626) owed to the director.

In other debtors is £857,025 (2022 - £1,770 (owed to)) owed by RoadtoHealth Group Limited.

10. ULTIMATE CONTROLLING PARTY

The ultimate controlling party is RoadtoHealth Group Limited.